• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Alafi Capital

edit

Alafi Capital is a private venture capital firm that has been active in healthcare investing for over 25 years. Early and mid-stage investments in the U.S. and Europe are considered, with emphasis on product-oriented biotechnology, life science technologies, imaging and diagnostics, and medical devices. Included among Alafi Capital’s past successes are Amgen, Biogen, Molecular Devices, Tanox, Qiagen, Novocor, Oxford Glycosciences, and Applied Biosystems.

Recent Milestones

edit

• 
  Alafi Capital invested in Kreatech Diagnostics. (1/31/10)
  Posted 2/1/10 at 8:26pm via onbiovc.com
• 
  Alafi Capital invested in Kreatech Diagnostics. (11/18/09)
  Posted 11/29/09 at 7:56pm via kreatech.com
• 
  Alafi Capital invested in Gene Security Network. (1/7/09)
  Posted 6/20/09 at 1:18am via reuters.com
• 
  Alafi Capital invested in Arcxis Biotechnologies. (10/1/07)
  Posted 4/17/09 at 9:12am via arcxis.com
• 
  Alafi Capital invested in Isto Technologies. (8/3/07)
  Posted 3/15/10 at 7:06pm via blogspot.com

Investments

Videos

Sources

1. Kreatech Diagnostics, BV: Series B $2.7M (onbiovc.com) [edit]
2. Kreatech (kreatech.com) [edit]
3. Gene Security Network Completes $6M Series B Financing (reuters.com) [edit]
4. ARCXIS BIOTECHNOLOGIES® SECURES SERIES B FINANCING (arcxis.com) [edit]
5. Isto Technolgies raise $8.8M (techstartupdatabase.blogspot.com) [edit]